JPMorgan Reinstates MBX Biosciences Inc (MBX) at Overweight

August 21, 2026 3:27 AM

JPMorgan analyst Jessica Fye reinstates coverage on MBX Biosciences Inc (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found